Please Wait
Applying Filters...
menu
    • menu
    Inabata France-PSE
    News
    AstraZeneca's 'smoker's lung' therapy meets main goals in trials

    02 May 2025

    // REUTERS

    Moderna targets more cost cuts amid uncertainty under RFK Jr.

    02 May 2025

    // FIERCE PHARM

    Concentra swoops in to purchase struggling Kronos

    02 May 2025

    // FIERCE BIOTECH

    Data Compilation
    #PharmaFlow

    Pharmasynthese

    Contact Supplier

    Website

    AMWC Asia-TDAC

    Not Confirmed

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    radio-compass-blog/top-pharma-companies-drugs-in-2024-merck-s-keytruda-maintains-top-spot-as-novo-s-semaglutide-nips-at-its-heels
    Left Arrow
    Right Arrow
    Related CompaniesRelated Companies

    About

    INABATA Group is a network of 60 subsidiaries in 20 countries worldwide, and overseas sales account for over 50% of consolidated net sales. Inabata France was founded in 1990, at first, to support chemical and pharmaceutical products exportation to Japan. Then Pharmasynthese was acquired in 2006, leading to internalization of a production site which is specialized in chemical synthesis. Today, Inabata/Pharmasynthese offers a wide variety of services including sourcing, manufacturing and development of raw materials mainly for pharmaceutic and cosmetic use.